These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28739996)

  • 1. [Tau Positron Emission Tomography].
    Higuchi M
    Brain Nerve; 2017 Jul; 69(7):819-823. PubMed ID: 28739996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau PET Imaging.
    Higuchi M
    Adv Exp Med Biol; 2019; 1184():217-230. PubMed ID: 32096041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloid Positron Emission Tomography in the Therapeutic Strategies for Alzheimer's Disease].
    Ishii K
    Brain Nerve; 2017 Jul; 69(7):809-818. PubMed ID: 28739995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    Whitwell JL; Tosakulwong N; Weigand SD; Graff-Radford J; Duffy JR; Clark HM; Machulda MM; Botha H; Utianski RL; Schwarz CG; Senjem ML; Strand EA; Ertekin-Taner N; Jack CR; Lowe VJ; Josephs KA
    J Alzheimers Dis; 2020; 74(1):377-389. PubMed ID: 32039841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report.
    Takaya M; Ishii K; Hosokawa C; Saigoh K; Shirakawa O
    Int Psychogeriatr; 2018 May; 30(5):641-646. PubMed ID: 29113604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.
    Villemagne VL; Okamura N
    Curr Opin Neurobiol; 2016 Feb; 36():43-51. PubMed ID: 26397020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with
    Tagai K; Ikoma Y; Endo H; Debnath OB; Seki C; Matsuoka K; Matsumoto H; Oya M; Hirata K; Shinotoh H; Takahata K; Kurose S; Sano Y; Ono M; Shimada H; Kawamura K; Zhang MR; Takado Y; Higuchi M
    Neuroimage; 2022 Dec; 264():119763. PubMed ID: 36427751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
    Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
    Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of tau PET radiotracers and their clinical applications.
    Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in Tau PET Imaging.
    Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
    Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voyage au bout de la nuit: Aβ and tau imaging in dementias.
    Zwan MD; Okamura N; Fodero-Tavoletti MT; Furumoto S; Masters CL; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):398-412. PubMed ID: 25358680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
    Matsuda H; Shigemoto Y; Sato N
    Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Tau and Its Ligands in PET Imaging.
    Harada R; Okamura N; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Biomolecules; 2016 Jan; 6(1):7. PubMed ID: 26751494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.